The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 4, 2006, Pages 635-643

  Amin, Zenab ^a   Mason, Graeme F ^a   Cavus, Idil ^a   Krystal, John H ^a   Rothman, Douglas L ^a   Epperson, C Neill ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Depression; Gamma aminobutyric acid; Magnetic resonance spectroscopy; Menopause; Postpartum depression; Premenstrual dysphoric disorder

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; ESTRADIOL; ESTROGEN; NEUROTRANSMITTER; PROGESTERONE; PROGESTERONE DERIVATIVE; STEROID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ARTICLE; CENTRAL NERVOUS SYSTEM; DATA ANALYSIS; DEPRESSION; DISEASE COURSE; FEMALE; HUMAN; MEDICAL RESEARCH; MENOPAUSE; MENTAL DISEASE; MOOD; NEUROENDOCRINE SYSTEM; NEUROLOGIC DISEASE; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PUERPERAL DEPRESSION; SMOKING CESSATION; SUBSTANCE ABUSE; ADDICTION; AFFECT; MENSTRUATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREMENSTRUAL SYNDROME; PSYCHOLOGICAL ASPECT; REVIEW;

AFFECT; DEPRESSION, POSTPARTUM; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MENSTRUATION; MENTAL DISORDERS; NEUROTRANSMITTER AGENTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREMENSTRUAL SYNDROME; SMOKING CESSATION; STEROIDS; SUBSTANCE-RELATED DISORDERS;

EID: 34248645660     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.06.007     Document Type: Article

References (96)

1. Altemus M., Fong J., Yang R., Damast S., Luine V., and Ferguson D. Changes in cerebrospinal fluid neurochemistry during pregnancy. Biol Psychiatry 56 (2004) 386-392
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author; 1994.
3. Andreen L., Bixo M., Nyberg S., Sundstrom-Poromaa I., and Backstrom T. Progesterone effects during sequential hormone replacement therapy. Eur J Endocrinol 148 (2003) 571-577
4. Bacci A., Huguenard J.R., and Prince D.A. Modulation of neocortical interneurons: extrinsic influences and exercises in self-control. Trends Neurosci 28 (2005) 602-610
5. Backstrom T., Andersson A., Andree L., Birzniece V., Bixo M., Bjorn I., et al. Pathogenesis in menstrual cycle-linked CNS disorders. Ann NY Acad Sci 1007 (2003) 42-53
6. Barik J., and Wonnacott S. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol Pharmacol 69 (2006) 618-628
7. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23 (2002) 41-100
8. Bitran D., and Smith S.S. Termination of pseudopregnancy in the rat produces an anxiogenic-like response that is associated with an increase in benzodiazepine receptor binding density and a decrease in GABA-stimulated chloride influx in the hippocampus. Brain Res Bull 64 (2005) 511-518
9. Bitran D., and Solano S.M. Termination of pseudopregnancy in the rat alters the response to progesterone, chlordiazepoxide, and MK-801 in the elevated plus-maze. Psychopharmacology 180 (2005) 447-454
10. Bjorn I., Bixo M., Nojd K.S., Nyberg S., and Backstrom T. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am J Obstet Gynecol 183 (2000) 1419-1426
11. Bjornson W., Rand C., Connett J.E., Lindgren P., Nides M., Pope F., et al. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health 85 (1995) 223-230
12. Brambilla P., Perez J., Barale F., Schettini G., and Soares J.C. GABAergic dysfunction in mood disorders. Mol Psychiatry 8 (2003) 721-737 [715]
13. Brandes M., Soares C.N., and Cohen L.S. Postpartum onset obsessive-compulsive disorder: diagnosis and management. Arch Women Ment Health 7 (2004) 99-110
14. Brockington I. Postpartum psychiatric disorders. Lancet 363 9405 (2004) 303-310
15. Cavus I., Kasoff W.S., Cassaday M.P., Jacob R., Gueorguieva R., Sherwin R.S., et al. Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol 57 (2005) 226-235
16. Cavus I., Krystal J., and Spencer D.D. Gender differences and menstrual cycle effects on brain extracellular glutamate and GABA levels in epileptic patients: a microdialysis study. Epilepsia 45 Suppl 7 (2004) 228
17. Concas A., Mostallino M.C., Porcu P., Follesa P., Barbaccia M.L., Trabucchi M., et al. Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A 95 (1998) 13284-13289
18. Epperson C.N., Haga K., Mason G.F., Sellers E., Gueorguieva R., Zhang W., et al. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59 (2002) 851-858
19. Epperson C.N., Gueorguieva R., Czarkowski K.A., Stiklus S., Sellers E., Krystal J.H., et al. Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology 186 (2006) 425-433
20. Epperson C.N., O'Malley S., Czarkowski K.A., Gueorguieva R., Jatlow P., Sanacora G., et al. Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry 57 (2005) 44-48
21. Foy M.R., Xu J., Xie X., Brinton R.D., Thompson R.F., and Berger T.W. 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J Neurophysiol 81 (1999) 925-929
22. Franklin T.R., Napier K., Ehrman R., Gariti P., O'Brien C.P., and Childress A.R. Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob Res 6 (2004) 171-175
23. Freeman E.W., Sammel M.D., Rinaudo P.J., and Sheng L. Premenstrual syndrome as a predictor of menopausal symptoms. Obstet Gynecol 103 (2004) 960-966
24. Fujii S., Jia Y., Yang A., and Sumikawa K. Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region. Brain Res 863 (2000) 259-265
25. Fuxe K., Andersson K., Eneroth P., Harfstrand A., and Agnati L.F. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocrinology 14 (1989) 19-41
26. Gavin N.I., Gaynes B.N., Lohr K.N., Meltzer-Brody S., Gartlehner G., and Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 106 (2005) 1071-1083
27. Gilbert Evans S.E., Ross L.E., Sellers E.M., Purdy R.H., and Romach M.K. 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol Endocrinol 21 5 (2005) 268-279
28. Goddard A.W., Mason G.F., Appel M., Rothman D.L., Gueorguieva R., Behar K.L., et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 161 (2004) 2186-2193
29. Gregory R.J., Masand P.S., and Yohai N.H. Depression across the reproductive life cycle: correlations between events. Prim Care Companion J Clin Psychiat 2 4 (2000) 127-129
30. Griffin L.D., and Mellon S.H. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A 96 (1999) 13512-13517
31. Gruber C.J., and Huber J.C. Differential effects of progestins on the brain. Maturitas 46 (2003) S71-S75
32. Heron J., Craddock N., and Jones I. Postnatal euphoria: are 'the highs' an indicator of bipolarity?. Bipolar Disord 7 2 (2005) 103-110
33. Irwin R.P., Lin S.Z., Rogawski M.A., Purdy R.H., and Paul S.M. Steroid potentiation and inhibition of N-methyl-d-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies. J Pharmacol Exp Ther 271 (1994) 677-682
34. Izzo E., Auta J., Impagnatiello F., Pesold C., Guidotti A., and Costa E. Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proc Natl Acad Sci U S A 98 (2001) 3483-3488
35. Joels M. Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol 18 (1997) 2-48
36. Kelly M.J., Qiu J., and Ronnekleiv O.K. Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system. Ann NY Acad Sci 1007 (2003) 6-16
37. Keverne E.B. GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses. Brain Res Bull 48 (1999) 467-473
38. Killen J.D., Fortmann S.P., Schatzberg A., Hayward C., and Varady A. Onset of major depression during treatment for nicotine dependence. Addict Behav 28 (2003) 461-470
39. Klatzkin R.R., Morrow A.L., Light K.C., Pedersen C.A., and Girdler S.S. Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol Psychol 71 (2006) 2-11
40. Kouri E.M., and Halbreich U. State and trait serotonergic abnormalities in women with dysphoric premenstrual syndromes. Psychopharmacol Bull 33 (1997) 767-770
41. Lambert J.J., Belelli D., Peden D.R., Vardy A.W., and Peters J.A. Neurosteroid modulation of GABAA receptors. Prog Neurobiol 71 (2003) 67-80
42. Lebon V., Petersen K.F., Cline G.W., Shen J., Mason G.F., Dufour S., et al. Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 22 (2002) 1523-1531
43. Levine M.D., Marcus M.D., and Perkins K.A. A history of depression and smoking cessation outcomes among women concerned about post-cessation weight gain. Nicotine Tob Res 5 (2003) 69-76
44. Li S.P., Park M.S., Kim J.H., and Kim M.O. Chronic nicotine and smoke treatment modulate dopaminergic activities in ventral tegmental area and nucleus accumbens and the gamma-aminobutyric acid type B receptor expression of the rat prefrontal cortex. J Neurosci Res 78 (2004) 868-879
45. Lindahl V., Pearson J.L., and Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Women Ment Health 8 (2005) 77-87
46. Lynch W.J., Roth M.E., and Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 164 (2002) 121-137
47. Mansvelder H.D., Keath J.R., and McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33 (2002) 905-919
48. Markou A., Paterson N.E., and Semenova S. Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation. Ann NY Acad Sci 1025 (2004) 491-503
49. Mason G.F., Gruetter R., Rothman D.L., Behar K.L., Shulman R.G., and Novotny E.J. Simultaneous determination of the rates of the TCA cycle, glucose utilization, α-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab 15 (1995) 12-25
50. Mellon S.H., and Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 13 (2002) 35-43
51. Melton L. Sex is all in the brain: report of a Novartis Foundation Symposium on the neuronal and cognitive effects of oestrogens, London, UK, 7-9 September 1999. Trends Endocrinol Metab 11 2 (2000) 69-71
52. Monteleone P., Luisi S., Tonetti A., Bernardi F., Genazzani A.D., Luisi M., et al. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142 (2000) 269-273
53. Mor G., Nilsen J., Horvath T., Bechmann I., Brown S., Garcia-Segura L.M., et al. Estrogen and microglia: a regulatory system that affects the brain. J Neurobiol 40 (1999) 484-496
54. Morrison M.F., Kallan M.J., Ten Have T., Katz I., Tweedy K., and Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55 (2004) 406-412
55. Murphy D.D., Cole N.B., Greenberger V., and Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci 18 (1998) 2550-2559
56. Nappi R.E., Petraglia F., Luisi S., Polatti F., Farina C., and Genazzani A.R. Serum allopregnanolone in women with postpartum "blues". Obstet Gynecol 97 (2001) 77-80
57. Nemeroff C.B. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 37 (2003) 133-146
58. Nyberg S., Andersson A., Zingmark E., Wahlstrom G., Backstrom T., and Sundstrom-Poromaa I. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls. Psychoneuroendocrinology 30 (2005) 892-901
59. Paoletti A.M., Romagnino S., Contu R., Orru M.M., Marotto M.F., Zedda P., et al. Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. Psychoneuroendocrinology (2006)
60. Parry B.L. The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications. CNS Drugs 15 (2001) 277-285
61. Paterson N.E., Froestl W., and Markou A. The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172 (2004) 179-186
62. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J 6 (1992) 2311-2322
63. Pearlstein T., Yonkers K.A., Fayyad R., and Gillespie J.A. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord 85 (2005) 275-282
64. Perkins K.A., Levine M., Marcus M., Shiffman S., D'Amico D., Miller A., et al. Tobacco withdrawal in women and menstrual cycle phase. J Consult Clin Psychol 68 (2000) 176-180
65. Pomerleau C.S., Mehringer A.M., Marks J.L., Downey K.K., and Pomerleau O.F. Effects of menstrual phase and smoking abstinence in smokers with and without a history of major depressive disorder. Addict Behav 25 (2000) 483-497
66. Porcu P., Sogliano C., Cinus M., Purdy R.H., Biggio G., and Concas A. Nicotine-induced changes in cerebrocortical neuroactive steroids and plasma corticosterone concentrations in the rat. Pharmacol Biochem Behav 74 (2003) 683-690
67. Raol Y.H., Zhang G., Budreck E.C., and Brooks-Kayal A.R. Long-term effects of diazepam and phenobarbital treatment during development on GABA receptors, transporters and glutamic acid decarboxylase. Neuroscience 132 (2005) 399-407
68. Rapkin A.J., Mikacich J.A., Moatakef-Imani B., and Rasgon N. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Curr Psychiatry Rep 4 (2002) 419-428
69. Rapkin A.J., Morgan M., Goldman L., Brann D.W., Simone D., and Mahesh V.B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90 (1997) 709-714
70. Reddy D.S. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 62 (2004) 99-118
71. Robinson G.E. Psychotic and mood disorders associated with the perimenopausal period: epidemiology, aetiology and management. CNS Drugs 15 (2001) 175-184
72. Schmidt P.J., Nieman L., Danaceau M.A., Tobin M.B., Roca C.A., Murphy J.H., et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183 (2000) 414-420
73. Schmidt P.J., Purdy R.H., Moore Jr. P.H., Paul S.M., and Rubinow D.R. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79 (1994) 1256-1260
74. Shen J., Petersen K.F., Behar K.L., Brown P., Nixon T.W., Mason G.F., et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A 96 (1999) 8235-8240
75. Sibson N.R., Dhankhar A., Mason G.F., Rothman D.L., Behar K.L., and Shulman R.G. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A 95 (1998) 316-321
76. Smith S.S. Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res 503 (1989) 354-357
77. Smith S.S. Pre-menstrual steroids. Cell Mol Life Sci 58 (2001) 1263-1275
78. Smith S.S., Waterhouse B.D., and Woodward D.J. Locally applied estrogens potentiate glutamate-evoked excitation of cerebellar Purkinje cells. Brain Res 475 (1988) 272-282
79. Smith M.J., Adams L.F., Schmidt P.J., Rubinow D.R., and Wassermann E.M. Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 54 (2003) 757-762
80. Smith S.S., Jorenby D.E., Leischow S.J., Nides M.A., Rennard S.I., Johnston J.A., et al. Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine Tob Res 5 (2003) 99-109
81. Smolen A., Smolen T.N., and Han P.C. Alterations in regional brain GABA concentration and turnover during pregnancy. Pharmacol Biochem Behav 44 (1993) 63-69
82. Soares C.N., Almeida O.P., Joffe H., and Cohen L.S. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58 (2001) 529-534
83. Sofuoglu M., Babb D.A., and Hatsukami D.K. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol Biochem Behav 69 (2001) 299-304
84. Steiner M., Dunn E., and Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord 74 (2003) 67-83
85. Steiner M., and Pearlstein T. Premenstrual dysphoria and the serotonin system pathophysiology and treatment. J Clin Psychiatry 61 Suppl 12 (2000) 17-21
86. Stewart D.E., and Boydell K.M. Psychologic distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 23 (1993) 157-162
87. Sundstrom I., Andersson A., Nyberg S., Ashbrook D., Purdy R.H., and Backstrom T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67 (1998) 126-138
88. Sundstrom I., and Backstrom T. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 23 (1998) 73-88
89. Sundstrom I., Nyberg S., and Backstrom T. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17 6 (1997) 370-381
90. Sundstrom Poromaa I., Smith S., and Gulinello M. GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Women Ment Health 6 (2003) 23-41
91. Uzunov D.P., Cooper T.B., Costa E., and Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci U S A 93 (1996) 12599-12604
92. Vawter M.P., Freed W.J., and Kleinman J.E. Neuropathology of bipolar disorder. Biol Psychiatry 48 (2000) 486-504
93. Wang M., Seippel L., Purdy R.H., and Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81 (1996) 1076-1082
94. Weiland N.G. Glutamic acid decarboxylase messenger ribonucleic acid is regulated by estradiol and progesterone in the hippocampus. Endocrinology 131 (1992) 2697-2702
95. Wetter D.W., Kenford S.L., Smith S.S., Fiore M.C., Jorenby D.E., and Baker T.B. Gender differences in smoking cessation. J Consult Clin Psychol 67 (1999) 555-562
96. Zhu P.J., and Chiappinelli V.A. Nicotine modulates evoked GABAergic transmission in the brain. J Neurophysiol 82 (1999) 3041-3045